Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 57,180 shares at $13.70 ($802K) on 2026-03-24, disclosed to the SEC on 2026-03-26.
Scheduled sale ($802k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.70 | 19,060 | $261K | 32.5% |
| 2 | $14.27 | 19,060 | $272K | 33.9% |
| 3 | $14.12 | 19,060 | $269K | 33.5% |
| Total | $14.03 avg | 57,180 | $802K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |